Innospec Inc. (NASDAQ:IOSP) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $86.00.
A number of equities analysts have recently issued reports on the stock. BidaskClub upgraded shares of Innospec from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 11th. KeyCorp increased their price target on shares of Innospec from $80.00 to $86.00 and gave the company an “overweight” rating in a report on Friday, July 13th. Finally, Zacks Investment Research downgraded shares of Innospec from a “hold” rating to a “sell” rating in a report on Wednesday.
A number of large investors have recently bought and sold shares of IOSP. Itau Unibanco Holding S.A. purchased a new position in Innospec during the 2nd quarter valued at about $116,000. UBS Group AG increased its holdings in Innospec by 69.3% during the 1st quarter. UBS Group AG now owns 2,771 shares of the specialty chemicals company’s stock valued at $190,000 after acquiring an additional 1,134 shares in the last quarter. Burney Co. purchased a new position in Innospec during the 2nd quarter valued at about $207,000. First Citizens Bank & Trust Co. purchased a new position in Innospec during the 2nd quarter valued at about $210,000. Finally, Diversified Trust Co purchased a new position in Innospec during the 2nd quarter valued at about $218,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Shares of IOSP traded up $0.80 during trading hours on Monday, reaching $76.95. The company had a trading volume of 99,265 shares, compared to its average volume of 63,987. The company has a quick ratio of 1.34, a current ratio of 2.28 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $1.86 billion, a PE ratio of 16.51 and a beta of 1.00. Innospec has a 12-month low of $56.15 and a 12-month high of $83.20.
Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, August 7th. The specialty chemicals company reported $1.00 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.05). The company had revenue of $358.10 million during the quarter. Innospec had a net margin of 4.45% and a return on equity of 13.83%. research analysts anticipate that Innospec will post 4.35 EPS for the current year.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.
Recommended Story: Intrinsic Value
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.